Cardio-oncology & otherCohort study
Accountable Care Organization Participation and Cardiovascular Care Quality
- Pre-post cohort study
- adjusted for secular trends
Authors' conclusion
Participation in an MSSP ACO was not found to be associated with early improvement in quality measures at outpatient cardiology practices.
Study context
- Population
- Patients at outpatient cardiology practices, NCDR PINNACLE Registry, January 1, 2013, through March 31, 201983 ACO vs 332 non-ACO practices
- Exposure
- Medicare Shared Savings Program (MSSP) ACO participation vs non-ACO cardiology practices
- ACOn = 83 practices; 2,390,244 patients
- Non-ACOn = 332 practices; 5,415,880 patientsreference
- Outcome
- 15 quality measures for CAD, HF, AF and hypertension
Main finding
As reported in the abstract
- MSSP ACO participation not associated with differential changes in performance measures for CAD, HF, AF and hypertension
Observational data: associations, not effects.
Further findings
| Outcome | aOR (95% CI) | P value | |
|---|---|---|---|
| ICD use (subset of traditional Medicare patients) · 12 months · increase following ACO participation · subset of traditional Medicare patients | 1.66 (1.12–2.45) | P = 0.01 | |
| 0.512Adjusted odds ratio (log scale) |
β-blocker use for HF (exploratory, follow-up extended to 24 months)
- Increase in β-blocker use for HF with ACO participation, aOR
- 1.23 (95% CI 1.02-1.49; P = .03)
- exploratory analysis
Low-density lipoprotein (LDL) profiles <100 mg/dL for CAD (exploratory, follow-up extended to 24 months)
- Decline in LDL profiles <100 mg/dL with ACO participation, aOR
- 0.71 (95% CI 0.51-0.999; P = .049)
- exploratory analysis
Original publication
Accountable Care Organization Participation and Cardiovascular Care Quality. JAMA Cardiol. Published 1 June 2025. doi:10.1001/jamacardio.2025.0381
Summarised from the published abstract; every number is checked against it